Solventum Corporation (SOLV) Stock Price, Quote & News

Company Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 651 733 1110

Website: www.solventum.com

Address:

3M Center, Building 275-6W-20 2510 Conway Avenue East St. Paul, Maplewood, United States

ZacksResearch Feb. 23 at 2:15 PM

$SOLV Q4 earnings preview: Will tariffs dampen the momentum? 🧐 Solventum's set to announce Q4 results after market close on Feb. 26. While volume growth and cost initiatives drive optimism, tariff headwinds could weigh on margins. The combination of a positive Earnings ESP and a Zacks Rank #1, 2 or 3 increases chances of an earnings beat, but this isn't the case here. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2873298/solventum-to-post-q4-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2873298-body-34559&ADID=SYND_STOCKTWITS_TWEET_2_2873298_BODY_34559

0 · Reply

ZacksResearch Feb. 23 at 1:15 PM

$SOLV heads into Q4 with momentum — but are tariff headwinds about to test the story? The company is riding solid momentum and leaning into M&A, yet investors are laser-focused on how margins and growth trends hold up against tariff pressure. ⚠️📊 See what could move the stock after earnings 👉 https://www.zacks.com/stock/news/2873298/solventum-to-post-q4-earnings-whats-in-store-for-the-stock?cid=sm-stocktwits-2-2873298-teaser-34558&ADID=SYND_STOCKTWITS_TWEET_2_2873298_TEASER_34558

0 · Reply

oldwisetrader Feb. 11 at 11:42 AM

$SUUN $SOLV on cnbc talking about solar

0 · Reply

SuperGreenToday Feb. 5 at 12:51 PM

$SOLV Share Price: $76.49 Contract Selected: Jul 17, 2026 $75 Calls Buy Zone: $7.65 – $9.45 Target Zone: $13.81 – $16.88 Potential Upside: 71% ROI Time to Expiration: 161 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

erevnon Jan. 26 at 11:38 AM

Keybanc upgrades Solventum $SOLV from Sector Weight to Overweight and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JFDI Jan. 20 at 3:09 PM

$SOLV 50d

0 · Reply

erevnon Jan. 20 at 3:02 PM

Mizuho upgrades Solventum $SOLV from Neutral to Outperform and raises the price target from $85 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

OfficialStocktwitsUser Jan. 15 at 9:49 PM

$SOLV RSI: 50.84, MACD: 0.4581 Vol: 2.25, MA20: 81.45, MA50: 80.12 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

bigbulldaddy Jan. 14 at 12:33 AM

$MDXG $RCEL $SOLV $VCEL I don’t think SOLV. We just bought restrata… we don’t need RCEL. Our teams could easily sell it into burn centers though.

1 · Reply

JHR Jan. 8 at 5:53 PM

$RCEL Who is going to acquire $RCEL in late 2026? $SOLV $MDXG $VCEL

0 · Reply

Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026

Dec 23, 2025, 4:05 PM EST - 2 months ago

Solventum Completes Acquisition of Acera Surgical

Dec 17, 2025, 4:05 PM EST - 2 months ago

Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy

Dec 16, 2025, 4:05 PM EST - 2 months ago

Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

Dec 11, 2025, 10:17 PM EST - 2 months ago

Solventum's Self-Help Is Ahead Of Schedule, But Sentiment Is Not

Dec 2, 2025, 12:23 PM EST - 2 months ago

Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Nov 25, 2025, 4:05 PM EST - 3 months ago

Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

Nov 20, 2025, 9:00 AM EST - 3 months ago

Solventum Announces $1 Billion Share Repurchase Program

Nov 20, 2025, 9:00 AM EST - 3 months ago

Solventum Announces Agreement to Acquire Acera Surgical

Nov 12, 2025, 1:51 PM EST - 3 months ago

Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference Transcript

Nov 11, 2025, 9:17 AM EST - 3 months ago

Solventum: A Mixed Q3 Provides Further Support For Our Neutral Stance

Nov 6, 2025, 7:26 PM EST - 3 months ago

Solventum Corporation (SOLV) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 3 months ago

Solventum Reports Third Quarter 2025 Financial Results

Nov 3, 2025, 4:05 PM EST - 4 months ago

Solventum to Participate in the 2025 Stifel Healthcare Conference

Oct 22, 2025, 12:42 PM EDT - 4 months ago

Solventum: A Solid Performance Here

Oct 21, 2025, 5:00 PM EDT - 4 months ago

Solventum Appoints Heather Knight as Chief Commercial Officer

Oct 16, 2025, 4:05 PM EDT - 4 months ago

Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025

Sep 9, 2025, 2:03 PM EDT - 5 months ago

Solventum Corporation (SOLV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 2:30 PM EDT - 6 months ago

Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers

Sep 8, 2025, 8:30 AM EDT - 6 months ago

Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers

Sep 5, 2025, 1:27 PM EDT - 6 months ago

Solventum Corporation (SOLV) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

Sep 2, 2025, 8:00 AM EDT - 6 months ago

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

TMO

Sep 2, 2025, 8:00 AM EDT - 6 months ago

Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business

TMO

Aug 28, 2025, 4:05 PM EDT - 6 months ago

Solventum to Participate in Upcoming Investor Conferences

Aug 22, 2025, 8:19 AM EDT - 6 months ago

Solventum Announces $1.75 Billion Note Tender Offers

Aug 13, 2025, 10:39 PM EDT - 6 months ago

Solventum Announces Pricing of Secondary Offering of Common Stock

Aug 13, 2025, 4:48 PM EDT - 6 months ago

Solventum Announces Launch of Secondary Offering of Common Stock

Aug 8, 2025, 6:53 AM EDT - 7 months ago

Solventum Corporation (SOLV) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:52 PM EDT - 7 months ago

Solventum raises annual profit forecast on strength in surgical equipment

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Solventum Reports Second Quarter 2025 Financial Results

Jul 22, 2025, 9:12 AM EDT - 7 months ago

Solventum: Appealing Again

Jul 17, 2025, 4:05 PM EDT - 7 months ago

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

Jun 18, 2025, 10:00 AM EDT - 8 months ago

Solventum Named a Best Company to Work for by U.S. News & World Report

Jun 3, 2025, 4:05 PM EDT - 9 months ago

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

May 11, 2025, 5:07 PM EDT - 10 months ago

Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript

May 9, 2025, 11:02 AM EDT - 10 months ago

Solventum Corporation: Cheap, With Caveats

May 8, 2025, 6:11 PM EDT - 10 months ago

Solventum beats first-quarter profit estimates on strong surgical product sales

May 8, 2025, 4:05 PM EDT - 10 months ago

Solventum to Participate in the 2025 BofA Securities Health Care Conference

May 8, 2025, 4:05 PM EDT - 10 months ago

Solventum Reports First Quarter 2025 Financial Results

Apr 17, 2025, 4:05 PM EDT - 11 months ago

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025

Mar 25, 2025, 6:00 PM EDT - 11 months ago

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

Mar 21, 2025, 12:44 PM EDT - 1 year ago

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy

Mar 20, 2025, 9:00 AM EDT - 1 year ago

Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Mar 12, 2025, 8:12 AM EDT - 1 year ago

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

Feb 28, 2025, 8:36 AM EST - 1 year ago

Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 5:09 PM EST - 1 year ago

Solventum forecasts annual profit above estimates on strong surgical product sales

Feb 27, 2025, 4:05 PM EST - 1 year ago

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Feb 26, 2025, 4:15 PM EST - 1 year ago

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Feb 26, 2025, 3:37 PM EST - 1 year ago

Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports

Feb 26, 2025, 2:50 PM EST - 1 year ago

Trian Comments on Solventum's Sale of its Purification & Filtration Business

TMO

ZacksResearch Feb. 23 at 2:15 PM

0 · Reply

ZacksResearch Feb. 23 at 1:15 PM

0 · Reply

oldwisetrader Feb. 11 at 11:42 AM

$SUUN $SOLV on cnbc talking about solar

0 · Reply

SuperGreenToday Feb. 5 at 12:51 PM

0 · Reply

erevnon Jan. 26 at 11:38 AM

Keybanc upgrades Solventum $SOLV from Sector Weight to Overweight and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JFDI Jan. 20 at 3:09 PM

$SOLV 50d

0 · Reply

erevnon Jan. 20 at 3:02 PM

Mizuho upgrades Solventum $SOLV from Neutral to Outperform and raises the price target from $85 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

OfficialStocktwitsUser Jan. 15 at 9:49 PM

0 · Reply

bigbulldaddy Jan. 14 at 12:33 AM

$MDXG $RCEL $SOLV $VCEL I don’t think SOLV. We just bought restrata… we don’t need RCEL. Our teams could easily sell it into burn centers though.

1 · Reply

JHR Jan. 8 at 5:53 PM

$RCEL Who is going to acquire $RCEL in late 2026? $SOLV $MDXG $VCEL

0 · Reply

JackDarwin Jan. 6 at 1:18 PM

$SOLV Bullish Engulfing Candletick Pattern. Wait for the confirmation from the next day's candle.

0 · Reply

BillionerOfKing Dec. 27 at 12:48 AM

$SOLV Current Stock Price: $80.45 Contracts to trade: $80 SOLV Jan 16 2026 Call Entry: $0.80 Exit: $1.44 ROI: 80% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

ZacksResearch Dec. 24 at 8:01 PM

$SOLV makes a bold move in advanced wound care — this one matters. Solventum is buying Acera Surgical for $725M upfront, entering the tissue matrices space and expanding its MedSurg and wound care portfolio — a clear strategic push into higher-value solutions. 🧠 See what this acquisition means for the business 👉 https://www.zacks.com/stock/news/2808854/solv-acquires-acera-surgical-to-expand-advanced-wound-care-portfolio?cid=sm-stocktwits-2-2808854-teaser-26335&ADID=SYND_STOCKTWITS_TWEET_2_2808854_TEASER_26335

0 · Reply

ZacksResearch Dec. 24 at 7:01 PM

$SOLV acquisition alert! 🏥💼 Solventum's $725M deal for Acera Surgical, with an additional $125M contingent payment, positions them in the fast-growing synthetic tissue matrices market. This move strengthens their MedSurg business and aligns with their transformation plan. Shares dipped 0.3% post-announcement, but SOLV's 7.4% gain over six months outpaces the industry's 2.3% growth — a noteworthy development. Discover the full strategic impact here 👉 https://www.zacks.com/stock/news/2808854/solv-acquires-acera-surgical-to-expand-advanced-wound-care-portfolio?cid=sm-stocktwits-2-2808854-body-26336&ADID=SYND_STOCKTWITS_TWEET_2_2808854_BODY_26336

0 · Reply

OfficialStocktwitsUser Dec. 24 at 3:40 PM

$SOLV RSI: 32.89, MACD: 0.6526 Vol: 2.17, MA20: 82.72, MA50: 77.15 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

bigbulldaddy Dec. 13 at 2:05 PM

$SOLV We bought ascera which is cool. Growth potential here. The restructure recently is a very interesting choice. They eliminated a key associate rep role that is responsible for managing the home rental VAC business through case managers. It also helped hospitals not lose expensive rental VAC units (which happens frequently). The clinical role was also eliminated which is another interesting choice with the product being difficult to use at times and needing clinical expertise. SOLV will definitely save money in sales expenditures but it really isn’t clear if this is a good idea. Their acute and post acute roles will have to pick up the slack for the missing roles. There will be balls dropped. Some of those balls will have consequences. They think they helped by making territories slightly smaller but it isn’t significantly different. I’m forecasting a hard Q1 while they try to bounce back from the restructure. Ascera restructure still coming…

0 · Reply

BillionerOfKing Dec. 3 at 3:40 PM

$SOLV Current Stock Price: $85.26 Contracts to trade: $85 SOLV Dec 19 2025 Call Entry: $2.00 Exit: $3.57 ROI: 79% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

JarvisFlow Dec. 2 at 11:05 AM

BTIG has adjusted their stance on Solventum ( $SOLV ), setting the rating to Buy with a target price of 100.

0 · Reply

StockBraker Nov. 28 at 2:07 PM

$SOLV Will buy if it dips to $70 or below.

1 · Reply

MACTEP Nov. 27 at 10:28 AM

$SOLV Doomed. Next target - $75

0 · Reply

danaos Nov. 23 at 11:01 PM

$SOLV Overweight

0 · Reply

ja1234567 Nov. 22 at 3:52 AM

$SOLV quite possibly the stupidest move I have seen in 5 years for any biotech company. Is the a word for overpaid to the point of insanity.

1 · Reply

Market Cap	12.65B
Revenue (ttm)	8.25B
Net Income (ttm)	478.00M
EPS (ttm)	N/A
PE Ratio	12.39
Forward PE	11.56
Profit Margin	5.79%
Debt to Equity Ratio	1.03

Volume	905,559
Avg Vol	1,026,206
Day's Range	N/A - N/A
Shares Out	173.45M
Stochastic %K	8%
Beta	0.35
Analysts	Sell
Price Target	$91.67